Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Laila AL-HALABI"'
Autor:
Michael Hust, David Fröde, Thomas Schirrmann, Laila Al-Halabi, Stefan Dübel, Anne Balck, Monika Michalzik, Stephanus Büttgenbach
Publikováno v:
mAbs. 5:140-149
C-reactive protein (CRP) is a serum marker highly upregulated in inflammation after bacterial infection. Robust, reliable and quick quantification of CRP would be a substitute for erythrocyte sedimentation rate (ESR) with superior diagnostic value. Q
Publikováno v:
Sensors & Transducers, Vol 127, Iss 4, Pp 102-111 (2011)
This paper presents a reusable microfluidic analysis system for point-of-care diagnostics of inflammation parameters in blood serum. Detection is achieved by using a mass sensitive quartz sensor. Immobilized specific antibody fragments designed for t
Autor:
Miriam Steinwand, Stefan Dübel, Michael Hust, Thomas Schirrmann, Saskia Helmsing, Laila Al-Halabi
Publikováno v:
New Biotechnology. 25:424-428
The new era of functional genomics demands several antibodies as specific detection reagents for proteins, their complexes and post-translational modifications. Only in vitro antibody selection technologies are able to provide the required throughput
Autor:
Laila Al-Halabi, Torsten Meyer
Publikováno v:
Antibody Engineering ISBN: 9783642011467
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8081d61b57a9e31aeb900f2612c38cf7
https://doi.org/10.1007/978-3-642-01147-4_17
https://doi.org/10.1007/978-3-642-01147-4_17
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 525
The increasing demand for recombinant antibodies as detection reagents in research, diagnostics, and therapy requires appropriate production systems. In contrast to antibody therapies, small recombinant antibody fragments like Fab and scFv are suffic
Publikováno v:
Therapeutic Antibodies ISBN: 9781934115923
The increasing demand for recombinant antibodies as detection reagents in research, diagnostics, and therapy requires appropriate production systems. In contrast to antibody therapies, small recombinant antibody fragments like Fab and scFv are suffic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b8faae20ddbfad98742413770cbb3ee
https://doi.org/10.1007/978-1-59745-554-1_27
https://doi.org/10.1007/978-1-59745-554-1_27
Publikováno v:
Frontiers in Bioscience. :4576
Recombinant antibodies are the fastest growing class of therapeutic proteins. Furthermore, antibodies are key detection reagents in research and diagnostics. The increasing demand for antibodies with regards to amount and quality resulted in the deve
Publikováno v:
Microbial Cell Factories
Microbial Cell Factories, Vol 6, Iss 1, p 38 (2007)
Microbial Cell Factories, Vol 6, Iss 1, p 38 (2007)
BackgroundThe demand on antigen binding reagents in research, diagnostics and therapy raises questions for novel antibody formats as well as appropriate production systems. Recently, the novel single chain Fab (scFab) antibody format combining proper